Patient Story

Published Last updated

Case Study Optic Nerve Hypoplasia Female, 16 months old, January - July 2011

Summary

Diagnosis

Sex

Age

Nationality

Optic Nerve Hypoplasia (ONH) / Septooptic Dysplasia (SOD)

Female

16 months

Irish

Injections

Cell type

Admission date

Discharge date

8

UCMSC

2011-01-16

2011-03-01

Condition On Admission

The patient had bilateral vision deterioration and a development delay since she was 5 months old. On physical examination her eyeballs were normal and pupils were equal and reactive to light. She could recognize light and darkness. Nystagmus was present. She could not look at objects and mostly let her head hang down to the floor when sitting.

Treatment Schedule

The patient received 8 umbilical cord-derived mesenchymal stem cell (UCMSC) packets by intravenous (IV) injections as per the schedule below:

Number

Date

Cell Type

Delivery Method

Side Effects

1

2011-01-19

UCMSC

Intravenous Injection

none reported

2

2011-01-21

UCMSC

Intravenous Injection

none reported

3

2011-01-24

UCMSC

Intravenous Injection

none reported

4

2011-01-28

UCMSC

Intravenous Injection

none reported

5

2011-02-11

UCMSC

Intravenous Injection

none reported

6

2011-02-16

UCMSC

Intravenous Injection

none reported

7

2011-02-21

UCMSC

Intravenous Injection

none reported

8

2011-02-25

UCMSC

Intravenous Injection

none reported

Condition at discharge

Stem cell treatment was completed without any adverse events or side effects. At the end of the treatment period the patient was able to reach out and grasp objects 50cm in front of her and track light with her eyes. There was also a decrease in the nystagmus.

Condition 1 month after treatment

One month after their daughter’s treatment the parents completed a Beike follow-up survey and in this survey they reported that their daughter had made significant progress in her physical condition and that her quality of life had significantly improved. At the time they also felt that new improvements were still being made by their daughter.

Condition 12 months after treatment

Please see an excerpt from the patient’s 12 month assessment below:

Symptom

Parents’ Assessment of Improvement

Blindness

Significant improvement

Light perception

Significant improvement

Ability to see hand movement

Significant improvement

Vision in left eye

Significant improvement

Vision in right eye

Significant improvement

Night vision

Significant improvement

Ability to see things at a close distance

Significant improvement

Nystagmus

Significant improvement

Strabismus

Significant improvement

Download Case Study

Internationally accredited

Held to global laboratory and biologics standards.